메뉴 건너뛰기
American Heart Journal
Volumn 154, Issue 5, 2007, Pages
Treating Chagas' cardiomyopathy patients with chronic heart failure
Author keywords

[No Author keywords available]
Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; SPIRONOLACTONE;
EID: 35548930694     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.07.050     Document Type: Letter
Times cited : (1)
References (4)
  • 1
    • 33947328740 scopus 로고    scopus 로고
    • A randomized trial of carvedilol after renin-angiotensin system inhibition in chronic Chagas' cardiomyopathy
    • Botoni F.A., Poole-Wilson P.A., Ribeiro A.L.P., et al. A randomized trial of carvedilol after renin-angiotensin system inhibition in chronic Chagas' cardiomyopathy. Am Heart J 153 (2007) 544.e1-544.e8
    • (2007) Am Heart J , vol.153
    • Botoni, F.A.1    Poole-Wilson, P.A.2    Ribeiro, A.L.P.3
  • 2
    • 20544453277 scopus 로고    scopus 로고
    • Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology
    • Swedberg K., Cleland J., Dargie H., et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 26 (2005) 1115-1140
    • (2005) Eur Heart J , vol.26 , pp. 1115-1140
    • Swedberg, K.1    Cleland, J.2    Dargie, H.3
  • 3
    • 2942609162 scopus 로고    scopus 로고
    • Do evidence-based treatments provide incremental benefits to patients with congestive heart failure already receiving angiotensin-converting enzyme inhibitors? A secondary analysis of one-year outcomes from the Assessment of Treatment with Lisinopril and Survival (ATLAS) study
    • Majumdar S.R., McAlister F.A., Cree M., et al. Do evidence-based treatments provide incremental benefits to patients with congestive heart failure already receiving angiotensin-converting enzyme inhibitors? A secondary analysis of one-year outcomes from the Assessment of Treatment with Lisinopril and Survival (ATLAS) study. Clin Ther 26 (2004) 694-703
    • (2004) Clin Ther , vol.26 , pp. 694-703
    • Majumdar, S.R.1    McAlister, F.A.2    Cree, M.3
  • 4
    • 26644463786 scopus 로고    scopus 로고
    • Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III
    • Willenheimer R., van Veldhuisen D.J., Silke B., et al. Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III. Circulation 112 (2005) 2426-2435
    • (2005) Circulation , vol.112 , pp. 2426-2435
    • Willenheimer, R.1    van Veldhuisen, D.J.2    Silke, B.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.